10-K Filing

Niagen Bioscience, Inc. CIK: 1386570 FY 2018

Filing Information

Form Type	10-K
Accession Number	`0001654954-19-002395`
Period End Date	20181231
Filing Date	20190307
Fiscal Year	2018
Fiscal Period	FY
XBRL Instance	cdxc-20181231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 76 Income Statement 42 Cash Flow Statement 80 Stockholders Equity 16

Balance Sheet 76 line items

Line Item	Tag	Value	Unit	Period
Restricted cash	`RestrictedCash`	-	USD	Point-in-time
Restricted cash	`RestrictedCash`	$200.00K	USD	Point-in-time
Allowance for receivable held at escrow	`AllowanceForReceivableHeldAtEscrow`	$100.00K	USD	Point-in-time
Allowance for receivable held at escrow	`AllowanceForReceivableHeldAtEscrow`	-	USD	Point-in-time
Allowance for doubtful accounts and returns	`AllowanceForDoubtfulAccountsReceivableCurrent`	$500.00K	USD	Point-in-time
Cash, including restricted cash of $0.2 million and $0, respectively	`Cash`	$22.62M	USD	Point-in-time
Allowance for doubtful accounts and returns	`AllowanceForDoubtfulAccountsReceivableCurrent`	$700.00K	USD	Point-in-time
Cash, including restricted cash of $0.2 million and $0, respectively	`Cash`	$45.39M	USD	Point-in-time
Cash, including restricted cash of $0.2 million and $0, respectively	`Cash`	$1.64M	USD	Point-in-time
Receivables from related party	`DueFromRelatedPartiesCurrent`	$700.00K	USD	Point-in-time
Trade receivables, net of allowances of $0.5 million and $0.7 million, respectively; Receivables from Related Party: $0.7 million and $1.0 million, respectively	`AccountsReceivableNetCurrent`	$4.36M	USD	Point-in-time
Receivables from related party	`DueFromRelatedPartiesCurrent`	$1.00M	USD	Point-in-time
Trade receivables, net of allowances of $0.5 million and $0.7 million, respectively; Receivables from Related Party: $0.7 million and $1.0 million, respectively	`AccountsReceivableNetCurrent`	$5.34M	USD	Point-in-time
Contract assets	`ContractWithCustomerAssetNet`	-	USD	Point-in-time
Common Stock, Par Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Contract assets	`ContractWithCustomerAssetNet`	$56.00K	USD	Point-in-time
Common Stock, Par Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Receivable held at escrow, net of allowance of $0.1 million	`ReceivableHeldAtEscrow`	-	USD	Point-in-time
Receivable held at escrow, net of allowance of $0.1 million	`ReceivableHeldAtEscrow`	$677.00K	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	55.09M	shares	Point-in-time
Inventories	`InventoryNet`	$8.25M	USD	Point-in-time
Inventories	`InventoryNet`	$5.80M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	56.70M	shares	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssets`	$577.00K	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssets`	$655.00K	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	55.09M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	54.70M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$57.18M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$36.53M	USD	Point-in-time
Leasehold Improvements and Equipment, net	`PropertyPlantAndEquipmentNet`	$2.87M	USD	Point-in-time
Leasehold Improvements and Equipment, net	`PropertyPlantAndEquipmentNet`	$3.58M	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$272.00K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$243.00K	USD	Point-in-time
Receivable held at escrow	`TradeAndLoansReceivablesHeldForSaleNetNotPartOfDisposalGroup`	-	USD	Point-in-time
Receivable held at escrow	`TradeAndLoansReceivablesHeldForSaleNetNotPartOfDisposalGroup`	$750.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.55M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.65M	USD	Point-in-time
Other Long-term Assets	`OtherAssetsNoncurrent`	$323.00K	USD	Point-in-time
Other Long-term Assets	`OtherAssetsNoncurrent`	-	USD	Point-in-time
Total assets	`Assets`	$42.23M	USD	Point-in-time
Total assets	`Assets`	$62.72M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.72M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$9.55M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.65M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$4.31M	USD	Point-in-time
Current maturities of capital lease obligations	`CapitalLeaseObligationsCurrent`	$196.00K	USD	Point-in-time
Current maturities of capital lease obligations	`CapitalLeaseObligationsCurrent`	$173.00K	USD	Point-in-time
Contract liabilities and customer deposits	`CustomerAdvancesAndDeposits`	$275.00K	USD	Point-in-time
Contract liabilities and customer deposits	`CustomerAdvancesAndDeposits`	$314.00K	USD	Point-in-time
Deferred rent, current	`DeferredRentCreditCurrent`	$114.00K	USD	Point-in-time
Deferred rent, current	`DeferredRentCreditCurrent`	$131.00K	USD	Point-in-time
Due to officer	`EmployeeRelatedLiabilitiesCurrent`	$100.00K	USD	Point-in-time
Due to officer	`EmployeeRelatedLiabilitiesCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$14.44M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.09M	USD	Point-in-time
Capital lease obligations, less current maturities	`CapitalLeaseObligationsNoncurrent`	$310.00K	USD	Point-in-time
Capital lease obligations, less current maturities	`CapitalLeaseObligationsNoncurrent`	$137.00K	USD	Point-in-time
Deferred rent, less current	`DeferredRentCreditNoncurrent`	$477.00K	USD	Point-in-time
Deferred rent, less current	`DeferredRentCreditNoncurrent`	$492.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$15.05M	USD	Point-in-time
Total Liabilities	`Liabilities`	$8.89M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $.001 par value; authorized 150,000 shares; issued and outstanding December 31, 2018 55,089 shares and December 30, 2017 54,697 shares	`CommonStockValue`	$55.00K	USD	Point-in-time
Common stock, $.001 par value; authorized 150,000 shares; issued and outstanding December 31, 2018 55,089 shares and December 30, 2017 54,697 shares	`CommonStockValue`	$55.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$116.88M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$110.38M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-89.75M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-56.60M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.97M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$27.18M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$53.83M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$42.23M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$62.72M	USD	Point-in-time

Income Statement 42 line items

Line Item	Tag	Value	Unit	Period
Sales, net	`Revenues`	$21.20M	USD	Annual
Sales, net	`Revenues`	$31.56M	USD	Annual
Cost of sales	`CostOfRevenue`	$10.72M	USD	Annual
Cost of sales	`CostOfRevenue`	$15.50M	USD	Annual
Gross profit	`GrossProfit`	$10.48M	USD	Annual
Gross profit	`GrossProfit`	$16.05M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$16.54M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$4.46M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$5.48M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$4.01M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$27.14M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$17.64M	USD	Annual
Other	`OtherExpenses`	$746.00K	USD	Annual
Other	`OtherExpenses`	$75.00K	USD	Annual
Operating expenses	`OperatingExpenses`	$49.23M	USD	Annual
Operating expenses	`OperatingExpenses`	$26.85M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-16.38M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-33.17M	USD	Annual
Interest expense, net	`InterestExpense`	$79.00K	USD	Annual
Interest expense, net	`InterestExpense`	$153.00K	USD	Annual
Other	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Other	`GainsLossesOnExtinguishmentOfDebt`	$-65.00K	USD	Annual
Nonoperating expenses	`NonoperatingIncomeExpense`	$-144.00K	USD	Annual
Nonoperating expenses	`NonoperatingIncomeExpense`	$-153.00K	USD	Annual
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-33.32M	USD	Annual
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-16.53M	USD	Annual
Loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-315.00K	USD	Annual
Loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	-	USD	Annual
Gain on sale of discontinued operations	`DisposalGroupNotDiscontinuedOperationGainLossOnDisposal`	-	USD	Annual
Gain on sale of discontinued operations	`DisposalGroupNotDiscontinuedOperationGainLossOnDisposal`	$5.47M	USD	Annual
Income from discontinued operations, net	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$5.15M	USD	Annual
Income from discontinued operations, net	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-33.32M	USD	Annual
Net loss	`NetIncomeLoss`	$-11.38M	USD	Annual
Loss from continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.61	USD	Annual
Loss from continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.37	USD	Annual
Earnings from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$0.11	USD	Annual
Earnings from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	-	USD	Annual
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.26	USD	Annual
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.61	USD	Annual
Basic and diluted weighted average common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	55,006.00	shares	Annual
Basic and diluted weighted average common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	44,599.00	shares	Annual

Cash Flow Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-33.32M	USD	Annual
Net loss	`NetIncomeLoss`	$-11.38M	USD	Annual
Depreciation of leasehold improvements and equipment	`Depreciation`	$510.00K	USD	Annual
Depreciation of leasehold improvements and equipment	`Depreciation`	$607.00K	USD	Annual
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$206.00K	USD	Annual
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$235.00K	USD	Annual
Share-based compensation expense	`AllocatedShareBasedCompensationExpense`	$4.61M	USD	Annual
Share-based compensation expense	`AllocatedShareBasedCompensationExpense`	$6.37M	USD	Annual
Allowance for doubtful trade receivables	`ProvisionForDoubtfulAccounts`	$-132.00K	USD	Annual
Allowance for doubtful trade receivables	`ProvisionForDoubtfulAccounts`	$-411.00K	USD	Annual
Gain from disposal of assets	`GainLossOnDispositionOfAssets`	$-5.47M	USD	Annual
Gain from disposal of assets	`GainLossOnDispositionOfAssets`	-	USD	Annual
Loss from disposal of equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.00K	USD	Annual
Loss from disposal of equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-5.00K	USD	Annual
Non-cash financing costs	`NoncashFinancingCosts`	$121.00K	USD	Annual
Non-cash financing costs	`NoncashFinancingCosts`	$70.00K	USD	Annual
Other Non-cash expense	`OtherNoncashExpense`	$65.00K	USD	Annual
Other Non-cash expense	`OtherNoncashExpense`	-	USD	Annual
Trade receivables	`IncreaseDecreaseInReceivables`	$937.00K	USD	Annual
Trade receivables	`IncreaseDecreaseInReceivables`	$1.11M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$2.18M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$-2.45M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$65.00K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-296.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$5.83M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.36M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.47M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$668.00K	USD	Annual
Customer deposits and other	`IncreaseDecreaseInCustomerDeposits`	$69.00K	USD	Annual
Customer deposits and other	`IncreaseDecreaseInCustomerDeposits`	$-68.00K	USD	Annual
Deferred rent	`IncreaseDecreaseInOtherDeferredLiability`	$180.00K	USD	Annual
Deferred rent	`IncreaseDecreaseInOtherDeferredLiability`	$2.00K	USD	Annual
Due to officer	`IncreaseDecreaseInDueToOfficersAndStockholders`	$-33.00K	USD	Annual
Due to officer	`IncreaseDecreaseInDueToOfficersAndStockholders`	$-100.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.80M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-20.91M	USD	Annual
Proceeds from disposal of assets, net of transaction costs	`ProceedsFromSaleOfProductiveAssets`	$5.95M	USD	Annual
Proceeds from disposal of assets, net of transaction costs	`ProceedsFromSaleOfProductiveAssets`	-	USD	Annual
Purchases of leasehold improvements and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.32M	USD	Annual
Purchases of leasehold improvements and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.17M	USD	Annual
Purchases of intangible assets	`PaymentsToAcquireIntangibleAssets`	$131.00K	USD	Annual
Purchases of intangible assets	`PaymentsToAcquireIntangibleAssets`	$184.00K	USD	Annual
Investment in other long-term assets	`PaymentsForProceedsFromInvestments`	-	USD	Annual
Investment in other long-term assets	`PaymentsForProceedsFromInvestments`	$323.00K	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.77M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$4.60M	USD	Annual
Proceeds from issuance of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$46.59M	USD	Annual
Proceeds from issuance of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$529.00K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$3.04M	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$404.00K	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Payment of debt issuance cost	`PaymentsOfDebtIssuanceCosts`	$75.00K	USD	Annual
Payment of debt issuance cost	`PaymentsOfDebtIssuanceCosts`	$19.00K	USD	Annual
Principal payments on capital leases	`RepaymentsOfDebtAndCapitalLeaseObligations`	$608.00K	USD	Annual
Principal payments on capital leases	`RepaymentsOfDebtAndCapitalLeaseObligations`	$196.00K	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$48.95M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-90.00K	USD	Annual
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$43.75M	USD	Annual
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-22.77M	USD	Annual
Cash Beginning of Year	`Cash`	$22.62M	USD	Point-in-time
Cash Beginning of Year	`Cash`	$45.39M	USD	Point-in-time
Cash Beginning of Year	`Cash`	$1.64M	USD	Point-in-time
Cash Ending of Year, including restricted cash $0.2 million for 2018	`Cash`	$22.62M	USD	Point-in-time
Cash Ending of Year, including restricted cash $0.2 million for 2018	`Cash`	$45.39M	USD	Point-in-time
Cash Ending of Year, including restricted cash $0.2 million for 2018	`Cash`	$1.64M	USD	Point-in-time
Cash payments for interest	`InterestPaidNet`	$41.00K	USD	Annual
Cash payments for interest	`InterestPaidNet`	$57.00K	USD	Annual
Adjustment to retained earnings: cumulative effect of initially applying ASC 606	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	-	USD	Annual
Adjustment to retained earnings: cumulative effect of initially applying ASC 606	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$164.00M	USD	Annual
Noncash consideration transferred for the acquisition of Healthspan Research LLC	`NoncashConsiderationTransferredForAcquisitionOfHealthspanResearchLlc`	-	USD	Annual
Noncash consideration transferred for the acquisition of Healthspan Research LLC	`NoncashConsiderationTransferredForAcquisitionOfHealthspanResearchLlc`	$1.19M	USD	Annual
Capital lease obligation incurred for purchases of equipment	`CapitalLeaseObligationsIncurred`	$515.00K	USD	Annual
Capital lease obligation incurred for purchases of equipment	`CapitalLeaseObligationsIncurred`	-	USD	Annual
Receivable from disposal of assets held at escrow	`ReceivableFromDisposalOfAssetsHeldAtEscrow`	$750.00K	USD	Annual
Receivable from disposal of assets held at escrow	`ReceivableFromDisposalOfAssetsHeldAtEscrow`	-	USD	Annual
Retirement of fully depreciated equipment - cost	`PropertyPlantAndEquipmentDisposals`	-	USD	Annual
Retirement of fully depreciated equipment - cost	`PropertyPlantAndEquipmentDisposals`	$57.00K	USD	Annual
Retirement of fully depreciated equipment - accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease`	$-57.00K	USD	Annual
Retirement of fully depreciated equipment - accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease`	-	USD	Annual

Stockholders Equity 16 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquity`	$9.97M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$27.18M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$53.83M	USD	Point-in-time
Adjustment to retained earnings: cumulative effect of initially applying ASC 606	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	-	USD	Annual
Adjustment to retained earnings: cumulative effect of initially applying ASC 606	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$164.00M	USD	Annual
Issuance of common stock, net of offering costs, Amount	`StockIssuedDuringPeriodValueNewIssues`	$47.59M	USD	Annual
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$529.00K	USD	Annual
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.04M	USD	Annual
Repurchase of common stock, Amount	`StockRepurchasedDuringPeriodValue`	$-404.00K	USD	Annual
Share-based compensation, Amount	`ShareBasedCompensation`	$6.37M	USD	Annual
Share-based compensation, Amount	`ShareBasedCompensation`	$4.61M	USD	Annual
Net loss	`NetIncomeLoss`	$-33.32M	USD	Annual
Net loss	`NetIncomeLoss`	$-11.38M	USD	Annual
Ending Balance, Amount	`StockholdersEquity`	$9.97M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$27.18M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$53.83M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.